GSK plc
Annual return
—
SPY
—
Alpha
—
Invested
$599.2M
Holdings
13
Trades YTD
1
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsIn development
Quarterly performance not yet computed for this fund.
The metrics pipeline computes return / SPY benchmark / alpha per quarter from this fund's 13F holdings and the SPY adj-close. It hasn't produced enough quarters here yet — the chart fills in automatically once at least two are on record.
Top holdings · current snapshot
Source: 13F-HR01
$CRSP
CRISPR THERAPEUTICS AG
Q4 2025: New position (3.22M shares)
25.6%
02
$WVE
WAVE LIFE SCIENCES LTD
Q4 2025: New position (18.25M shares)
22.1%
03
$BNTX
BIONTECH SE
Q4 2025: New position (889.8k shares)
13.2%
04
$VIR
VIR BIOTECHNOLOGY INC
Q4 2025: New position (8.55M shares)
12.8%
05
$IDYA
IDEAYA BIOSCIENCES INC
Q4 2025: New position (1.33M shares)
7.4%
06
$LYEL
LYELL IMMUNOPHARMA INC
Q4 2025: New position (1.51M shares)
5.1%
07
$CYTK
CYTOKINETICS INC
Q4 2025: New position (340.4k shares)
3.7%
08
$SPRO
SPERO THERAPEUTICS INC
Q4 2025: New position (9.19M shares)
3.6%
09
$FULC
FULCRUM THERAPEUTICS INC
Q4 2025: New position (1.79M shares)
2.3%
10
$CVRX
CVRX INC
Q4 2025: New position (1.01M shares)
1.6%
Recent trades · Last 90 days
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Last refreshed 10:37 UTC.